Vaporizing Chest Rub

Description

The drug is formulated as a vaporizing chest rub, designed for topical application. The effective date of the insert is November 25, 2014. An accompanying image of the product is available, labeled as "vaporising-chest-rub.jpg".

Uses and Indications

This drug is indicated for the temporary relief of cough associated with common cold and minor bronchial irritation when applied to the chest and throat. Additionally, it is indicated for the temporary relief of pain associated with minor skin irritation.

Limitations of Use: This drug is not intended for the treatment of chronic cough or cough associated with smoking, asthma, or emphysema. It should be used with caution in patients with underlying respiratory conditions.

Dosage and Administration

For adults and children aged 2 years and older, a thick layer of the product should be applied topically to the chest and throat. It is recommended to keep clothing loose around the chest and throat area to facilitate the inhalation of vapors through the nose and mouth. This application may be performed up to three times daily, as directed by a healthcare professional.

For children under 2 years of age, it is advised to consult a doctor before use.

Contraindications

Use of this product is contraindicated in the following situations:

• Administration by mouth is prohibited.

• Application in the nostrils is not permitted.

• Use in conjunction with tight bandages is contraindicated.

• Application on wounds or damaged skin is not advised.

• Use is contraindicated in patients with persistent or chronic cough, including those with asthma, emphysema, or a history of smoking.

• Heating the product, including microwaving or adding to hot water, is not allowed due to the risk of splattering and potential burns.

Warnings and Precautions

For external use only; contact with eyes should be avoided. The product is contraindicated for oral ingestion or placement in the nostrils.

General precautions must be observed to ensure safe use. The product should not be applied by mouth or used in the nostrils. It is also advised against using the product with tight bandages or on wounds and damaged skin. Caution is warranted in patients with persistent or chronic cough, such as those associated with asthma, emphysema, or smoking, as the product is not recommended for these conditions.

In the event of ingestion, immediate medical assistance should be sought, or a Poison Control Center should be contacted without delay.

Healthcare professionals should advise patients to discontinue use and consult a physician if a cough persists for more than 7 days, recurs, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition.

Side Effects

Patients should be aware that the product is for external use only and must avoid contact with the eyes. It is contraindicated for oral ingestion or placement in the nostrils.

In clinical practice, patients are advised to stop using the product and consult a healthcare professional if they experience a cough that lasts more than 7 days, recurs, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition.

Additionally, patients should seek medical advice if they have a cough that occurs with excessive phlegm (mucus), as this may require further evaluation.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Vaporizing Chest Rub (menthol and camphor and eucalyptus oil). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the recommended application involves rubbing a thick layer on the chest and throat, ensuring that clothing is kept loose around these areas to facilitate the inhalation of vapors. This product may be used up to three times daily as directed by a healthcare provider.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The product has not been evaluated for safety during pregnancy. While there are no specific contraindications listed, caution is advised due to the presence of active ingredients such as camphor, menthol, and eucalyptus oil, which may pose potential risks. Currently, there are no specific warnings or safety concerns associated with the use of this product during pregnancy. Additionally, no dosage modifications are provided for pregnant individuals, and no special precautions are mentioned for use during this period. Healthcare professionals should weigh the potential benefits against any unknown risks when considering this product for pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of this product by nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of the reach of children to prevent accidental ingestion. In the event of ingestion, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be instructed not to use this product by mouth or in the nostrils. It is important to inform patients that this product should not be used with tight bandages, on wounds, or on damaged skin. Additionally, patients should be cautioned against using this product if they have a persistent or chronic cough, such as that associated with asthma, emphysema, or smoking.

Healthcare providers should emphasize the importance of discontinuing use and consulting a doctor if a cough lasts more than 7 days, returns, or occurs alongside fever, rash, or a persistent headache, as these symptoms may indicate a serious condition.

When using this product, patients should be advised not to heat it, microwave it, or add it to hot water or any container that is used for heating water, as this may cause splattering and result in burns. Lastly, patients should be encouraged to consult their doctor if they experience a cough that is accompanied by excessive phlegm (mucus).

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded after use to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically and may be used up to three times daily as directed by a healthcare provider. Clinicians should advise patients to keep the product out of the reach of children. In the event of ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Information (PDF)

This file contains official product information for Vaporizing Chest Rub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)